News

Filter

Current filters:

Licensing

951 to 960 of 97217 results

Moshe Manor appointed president and chief executive of Protalix BioTherapeutics

Moshe Manor appointed president and chief executive of Protalix BioTherapeutics

29-09-2014

Israeli pharma company Protalix BioTherapeutics has appointed Moshe Manor as its new president and chief…

BoardroomIsraelPharmaceuticalPresident and chief executiveProtalix BioTherapeutics

ESMO 2014: Novartis’ Afinitor; and Janssen’s Zytiga

ESMO 2014: Novartis’ Afinitor; and Janssen’s Zytiga

28-09-2014

Swiss pharma major Novartis on Saturday presented final results on overall survival (OS) from a Phase…

AfinitorJanssenJohnson & JohnsonNovartisOncologyPharmaceuticalResearchSpainZytiga

US FDA approves Iluvien for diabetic macular edema

US FDA approves Iluvien for diabetic macular edema

28-09-2014

US ophthalmic drug specialist Alimera Sciences says that the US Food and Drug Administration has approved…

Alimera SciencesIluvienMedidurOphthalmicsPharmaceuticalpSividaRegulationTethadurUSA

Bayer’s Jadelle to be listed in New Zealand

Bayer’s Jadelle to be listed in New Zealand

26-09-2014

New Zealand’s Pharmaceutical Management Agency PHARMAC has announced the approval of an agreement with…

BayerJadelleMarkets & MarketingNew ZealandPharmaceuticalPricingReproductiveWomen's Health

951 to 960 of 97217 results

Back to top